|
Volumn 183, Issue 3, 2002, Pages 274-279
|
A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer
|
Author keywords
Antineoplastic agents; Esophageal neoplasms surgery; Meta analysis; Postoperative complications; Prospective studies; Randomized controlled trial
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER RECURRENCE;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
DRUG INDUCED DISEASE;
ESOPHAGUS CARCINOMA;
ESOPHAGUS RESECTION;
HUMAN;
LUNG DISEASE;
MEDLINE;
META ANALYSIS;
OUTCOMES RESEARCH;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
SURGICAL MORTALITY;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
ESOPHAGEAL NEOPLASMS;
ESOPHAGECTOMY;
FEMALE;
HUMANS;
MALE;
NEOPLASM STAGING;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
REFERENCE VALUES;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 0036211951
PISSN: 00029610
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9610(02)00795-X Document Type: Article |
Times cited : (212)
|
References (34)
|